SCHEMBL24718390

SCHEMBL24718390

O=C(O)c1ccccc1C(=O)NC1CC(=O)N(Cc2ccc(Cl)c(Cl)c2)C1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ ALDH1A1 P00352 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ SIGMAR1 Q99720 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ LIPG Q9Y5X9 2/20 0.44
▸ P2RX7 Q99572 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ PTPRG P23470 1/20 0.41
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24719109 0.90 MEN1 (0.47) MEN1KMT2AALDH1A1GAASIGMAR1
SCHEMBL24718422 0.83 MEN1 (0.55) MEN1KMT2AALDH1A1GAASIGMAR1
SCHEMBL24718657 0.81 SMN1; SMN2 (0.44) MEN1KMT2AALDH1A1GAALMNA
SCHEMBL24719112 0.81 SMN1; SMN2 (0.44) MEN1KMT2AALDH1A1GAALMNA
SCHEMBL24719133 0.81 SMN1; SMN2 (0.44) MEN1KMT2AALDH1A1GAALMNA
SCHEMBL24718400 0.80 MEN1 (0.51) MEN1KMT2AALDH1A1TDP1
SCHEMBL24718379 0.79 POLB (0.45) ALDH1A1GAALMNAMAPTPOLB
SCHEMBL24719124 0.79 MEN1 (0.50) MEN1KMT2AALDH1A1MAPT
SCHEMBL24718644 0.77 ALDH1A1 (0.42) MEN1KMT2AALDH1A1GAAPOLB
SCHEMBL24718827 0.75 TP53 (0.49) MEN1KMT2AALDH1A1GAASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 MEN1 3534/4885KMT2A 180/4885ALDH1A1 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback